Quantity size:

0.2ml

Concentration:

1mg/ml 分选连接蛋白9抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Sorting nexin (SNX) proteins are members of a large family of hydrophilic PX (phospholipid-binding motif) domain-containing proteins that interact with a variety of receptor types. SNXs are widely expressed, although the tissue distribution of each SNX mRNA varies. The ability of SNXs to bind specific phospholipids, as well as their tendency to form protein-protein complexes, suggests a role for these proteins in cellular membrane trafficking and protein sorting. SNXs may also function 分选连接蛋白9抗体specifically in pro-degradative sorting, internalization, endosomal recycling or simply in endosomal sorting. SNXs partially associate with cellular membranes, despite their hydrophilic nature. SNX9 resides in the cytosol where it influences the processing and trafficking of insulin receptors. The enzyme aldolase binds to and inactivates SNX9. Phosphorylation of SNX9分选连接蛋白9抗体 releases aldolase and frees SNX9 to recruit and activate Dynamin II, a neuronal phosphoprotein and a GTPase enzyme which mediates late stages of endocytosis in both neural and non-neural cells.

Also known as:

MST 155; MST155; MSTP 155; MSTP155; OTTHUMP00000040083; Protein SDP 1; Protein SDP1; SDP 1; SDP1; SH3 and PX domain containing protein 3A; SH3 and PX domain containing protein SH3PX1; SH3 and PX domain-containing protein 1; SH3 and PX domain-containing protein 分选连接蛋白9抗体3A; SH3PX1; SH3PXD3A; SNX 9; SNX9; SNX9_HUMAN; Sorting nexin 9; Sorting nexin-9; WASP interactor protein; Wiskott Aldrich syndrome protein (WASP) interactor protein; Wiskott Aldrich syndrome protein interactor protein; WISP.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .

●

Immunogen: KLH conjugated synthetic peptide derived from human SNX5.

●

分选连接蛋白9抗体Predicted Molecular Weight: 67kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user

kl013Hu01骨成型蛋白2(BMP2)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)

kl013Mu01骨成型蛋白2(BMP2)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)

kl013Po01骨成型蛋白2(BMP2)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)

kl013Ra01骨成型蛋白2(BMP2)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)

kl013Rb52骨成型蛋白2(BMP2)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)

kl014Bo01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)

kl014Ca01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)

kl014Cp01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)

kl014Ga01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)

kl014Po01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)

kl014Rb53骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)

kl015Hu01骨成型蛋白受体1A(BMPR1A)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)

kl015Mu01骨成型蛋白受体1A(BMPR1A)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)

kl015Ra01骨成型蛋白受体1A(BMPR1A)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)

kl017Bo01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)

kl017Ga01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)

kl017Hu01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)

kl017Mu01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)

kl017Po01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)

kl017Ra01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)

kl019Hu01白介素8受体α(IL8Rα)多克隆抗体Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)